F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Metabolic dysfunction-associated fatty liver disease

Page 1 of 1 ( 35 items )
<<
1
>>

1	Beyond biomarkers: An integrated traditional Chinese medicine-machine learning approach predicts hepatic steatosis in high metabolic risk populations 10/14/2025 7:41:44 AM \| Browse: 99 \| Download: 193
2	Exploring the interplay between metabolic dysfunction-associated fatty liver disease and gut dysbiosis: Pathophysiology, clinical implications, and emerging therapies 8/27/2025 9:21:12 AM \| Browse: 198 \| Download: 440
3	Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease 7/24/2025 7:47:21 AM \| Browse: 91 \| Download: 228
4	Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study 6/26/2025 7:27:57 AM \| Browse: 127 \| Download: 664
5	Correlation between gynecomastia and endocrine regulation in patients with metabolic dysfunction-associated fatty liver disease: A cross-sectional study 6/26/2025 7:27:56 AM \| Browse: 140 \| Download: 696
6	Cardiovascular implications of metabolic dysfunction-associated fatty liver disease and type 2 diabetes mellitus: A meta-analysis 5/27/2025 7:04:46 AM \| Browse: 92 \| Download: 501
7	Rethinking carnitine palmitoyltransferase-II and liver stem cells in metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma 4/18/2025 7:43:21 AM \| Browse: 127 \| Download: 391
8	Carnitine palmitoyltransferase-II inactivity promotes malignant progression of metabolic dysfunction-associated fatty liver disease via liver cancer stem cell activation 11/26/2024 7:20:29 AM \| Browse: 149 \| Download: 719
9	Inflammatory biomarkers as cost-effective predictive tools in metabolic dysfunction-associated fatty liver disease 11/26/2024 7:20:28 AM \| Browse: 173 \| Download: 513
10	Enhancing the functionality of mesenchymal stem cells: An attractive treatment strategy for metabolic dysfunction-associated steatotic liver disease? 10/25/2024 2:40:46 AM \| Browse: 182 \| Download: 634
11	Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction 7/26/2024 10:33:29 AM \| Browse: 198 \| Download: 825
12	Exploring non-invasive diagnostics for metabolic dysfunction-associated fatty liver disease 7/24/2024 6:41:09 AM \| Browse: 200 \| Download: 647
13	Novel insights into autophagy in gastrointestinal pathologies, mechanisms in metabolic dysfunction-associated fatty liver disease and acute liver failure 7/11/2024 8:47:17 AM \| Browse: 174 \| Download: 687
14	Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease 7/1/2024 7:39:37 AM \| Browse: 237 \| Download: 949
15	Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology. Long life to the old biomarker ! 6/25/2024 10:41:21 AM \| Browse: 191 \| Download: 820
16	Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease 6/21/2024 3:14:32 AM \| Browse: 184 \| Download: 640
17	Screening for metabolic-dysfunction associated fatty liver disease: Time to discard the emperor's clothes of normal liver enzymes? 6/6/2024 5:43:14 AM \| Browse: 235 \| Download: 861
18	Update in lean metabolic dysfunction-associated steatotic liver disease 3/27/2024 1:28:19 PM \| Browse: 214 \| Download: 710
19	Current remarks and future directions on the interactions between metabolic dysfunction-associated fatty liver disease and COVID-19 3/21/2024 11:37:41 AM \| Browse: 308 \| Download: 795
20	Predictive value of angiopoietin-like protein 8 in metabolic dysfunction-associated fatty liver disease and its progression: A case-control study 3/15/2024 9:49:52 AM \| Browse: 296 \| Download: 1094
21	Cumulative effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease in China 3/14/2024 5:31:16 PM \| Browse: 340 \| Download: 1259
22	Impact of microplastics and nanoplastics on liver health: Current understanding and future research directions 3/6/2024 6:10:51 AM \| Browse: 328 \| Download: 822
23	From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus 12/25/2023 6:03:15 AM \| Browse: 355 \| Download: 1036
24	Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide study 12/1/2023 6:03:41 AM \| Browse: 245 \| Download: 1467
25	Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023) 9/25/2023 9:07:43 AM \| Browse: 408 \| Download: 1225
26	Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors 8/22/2023 7:39:26 AM \| Browse: 364 \| Download: 1450
27	Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations 10/18/2022 8:29:59 AM \| Browse: 726 \| Download: 1433
28	Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows 9/9/2022 12:48:14 PM \| Browse: 604 \| Download: 1440
29	Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations? 2/22/2022 9:25:37 AM \| Browse: 753 \| Download: 1836
30	Nonalcoholic fatty liver disease shows significant sex dimorphism 2/11/2022 5:55:19 AM \| Browse: 650 \| Download: 1790
31	De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation 12/27/2021 5:24:00 AM \| Browse: 740 \| Download: 1584
32	Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: A systematic review and meta-analysis 7/23/2021 8:10:13 AM \| Browse: 722 \| Download: 2458
33	Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease 5/13/2021 10:05:39 AM \| Browse: 762 \| Download: 2037
34	COVID-19 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight 4/21/2021 5:56:26 AM \| Browse: 856 \| Download: 1834
35	Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic-Chinese population 12/18/2020 5:58:43 AM \| Browse: 959 \| Download: 2428

Page 1 of 1 ( 35 items )
<<
1
>>

1	Beyond biomarkers: An integrated traditional Chinese medicine-machine learning approach predicts hepatic steatosis in high metabolic risk populations 10/14/2025 7:41:44 AM \| Browse: 99 \| Download: 193
2	Exploring the interplay between metabolic dysfunction-associated fatty liver disease and gut dysbiosis: Pathophysiology, clinical implications, and emerging therapies 8/27/2025 9:21:12 AM \| Browse: 198 \| Download: 440
3	Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease 7/24/2025 7:47:21 AM \| Browse: 91 \| Download: 228
4	Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study 6/26/2025 7:27:57 AM \| Browse: 127 \| Download: 664
5	Correlation between gynecomastia and endocrine regulation in patients with metabolic dysfunction-associated fatty liver disease: A cross-sectional study 6/26/2025 7:27:56 AM \| Browse: 140 \| Download: 696
6	Cardiovascular implications of metabolic dysfunction-associated fatty liver disease and type 2 diabetes mellitus: A meta-analysis 5/27/2025 7:04:46 AM \| Browse: 92 \| Download: 501
7	Rethinking carnitine palmitoyltransferase-II and liver stem cells in metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma 4/18/2025 7:43:21 AM \| Browse: 127 \| Download: 391
8	Carnitine palmitoyltransferase-II inactivity promotes malignant progression of metabolic dysfunction-associated fatty liver disease via liver cancer stem cell activation 11/26/2024 7:20:29 AM \| Browse: 149 \| Download: 719
9	Inflammatory biomarkers as cost-effective predictive tools in metabolic dysfunction-associated fatty liver disease 11/26/2024 7:20:28 AM \| Browse: 173 \| Download: 513
10	Enhancing the functionality of mesenchymal stem cells: An attractive treatment strategy for metabolic dysfunction-associated steatotic liver disease? 10/25/2024 2:40:46 AM \| Browse: 182 \| Download: 634
11	Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction 7/26/2024 10:33:29 AM \| Browse: 198 \| Download: 825
12	Exploring non-invasive diagnostics for metabolic dysfunction-associated fatty liver disease 7/24/2024 6:41:09 AM \| Browse: 200 \| Download: 647
13	Novel insights into autophagy in gastrointestinal pathologies, mechanisms in metabolic dysfunction-associated fatty liver disease and acute liver failure 7/11/2024 8:47:17 AM \| Browse: 174 \| Download: 687
14	Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease 7/1/2024 7:39:37 AM \| Browse: 237 \| Download: 949
15	Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology. Long life to the old biomarker ! 6/25/2024 10:41:21 AM \| Browse: 191 \| Download: 820
16	Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease 6/21/2024 3:14:32 AM \| Browse: 184 \| Download: 640
17	Screening for metabolic-dysfunction associated fatty liver disease: Time to discard the emperor's clothes of normal liver enzymes? 6/6/2024 5:43:14 AM \| Browse: 235 \| Download: 861
18	Update in lean metabolic dysfunction-associated steatotic liver disease 3/27/2024 1:28:19 PM \| Browse: 214 \| Download: 710
19	Current remarks and future directions on the interactions between metabolic dysfunction-associated fatty liver disease and COVID-19 3/21/2024 11:37:41 AM \| Browse: 308 \| Download: 795
20	Predictive value of angiopoietin-like protein 8 in metabolic dysfunction-associated fatty liver disease and its progression: A case-control study 3/15/2024 9:49:52 AM \| Browse: 296 \| Download: 1094
21	Cumulative effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease in China 3/14/2024 5:31:16 PM \| Browse: 340 \| Download: 1259
22	Impact of microplastics and nanoplastics on liver health: Current understanding and future research directions 3/6/2024 6:10:51 AM \| Browse: 328 \| Download: 822
23	From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus 12/25/2023 6:03:15 AM \| Browse: 355 \| Download: 1036
24	Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide study 12/1/2023 6:03:41 AM \| Browse: 245 \| Download: 1467
25	Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023) 9/25/2023 9:07:43 AM \| Browse: 408 \| Download: 1225
26	Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors 8/22/2023 7:39:26 AM \| Browse: 364 \| Download: 1450
27	Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations 10/18/2022 8:29:59 AM \| Browse: 726 \| Download: 1433
28	Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows 9/9/2022 12:48:14 PM \| Browse: 604 \| Download: 1440
29	Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations? 2/22/2022 9:25:37 AM \| Browse: 753 \| Download: 1836
30	Nonalcoholic fatty liver disease shows significant sex dimorphism 2/11/2022 5:55:19 AM \| Browse: 650 \| Download: 1790
31	De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation 12/27/2021 5:24:00 AM \| Browse: 740 \| Download: 1584
32	Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: A systematic review and meta-analysis 7/23/2021 8:10:13 AM \| Browse: 722 \| Download: 2458
33	Individualized treatment options for patients with non-cirrhotic and cirrhotic liver disease 5/13/2021 10:05:39 AM \| Browse: 762 \| Download: 2037
34	COVID-19 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight 4/21/2021 5:56:26 AM \| Browse: 856 \| Download: 1834
35	Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic-Chinese population 12/18/2020 5:58:43 AM \| Browse: 959 \| Download: 2428